Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making

Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making

Glen J Weiss,1 Brandi R Hoff,1 Robert P Whitehead,1 Ashish Sangal,1 Susan A Gingrich,1 Robert J Penny,2 David W Mallery,2 Scott M Morris,2 Eric J Thompson,2 David M Loesch,2 Vivek Khemka1 1Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, AZ, USA; 2Paradigm Diagnostics...

Full description

Bibliographic Details
Main Authors: Weiss GJ, Hoff BR, Whitehead RP, Sangal A, Gingrich SA, Penny RJ, Mallery DW, Morris SM, Thompson EJ, Loesch DM, Khemka V
Format: Article
Language:English
Published: Dove Medical Press 2015-04-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/evaluation-and-comparison-of-two-commercially-available-targeted-next--peer-reviewed-article-OTT

Internet

http://www.dovepress.com/evaluation-and-comparison-of-two-commercially-available-targeted-next--peer-reviewed-article-OTT

Similar Items